Goldman Sachs Group Inc Genetron Holdings LTD Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 14, 2024	SELL	$0.8 - $1.12 $218,574 - $306,004	-273,218 Reduced 91.04%	26,886 $30,000
Q4 2022 Feb 13, 2023	BUY	$0.8 - $1.12 $21,508 - $30,112	26,886 New	26,886 $30,000
Q2 2022 May 14, 2024	BUY	$1.28 - $2.4 $384,133 - $720,249	300,104 New	300,104 $510,000
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.4 $71,815 - $134,654	-56,106 Reduced 15.75%	300,104 $510,000
Q1 2022 May 16, 2022	SELL	$2.19 - $6.09 $44,954 - $125,009	-20,527 Reduced 5.45%	356,210 $780,000
Q4 2021 Feb 14, 2022	SELL	$5.81 - $14.39 $529,738 - $1.31 Million	-91,177 Reduced 19.49%	376,737 $2.3 Million
Q3 2021 Nov 10, 2021	BUY	$11.55 - $20.3 $5.4 Million - $9.5 Million	467,914 New	467,914 $6.48 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.